MRBL.CN
Marble Financial Inc
Price:
0.05
CAD
Volume:
17,500
Canada | Finance and Insurance
No data available for this ticker
MRBL.CN Probability of Bankruptcy
The Probability of Bankruptcy of Marble Financial Inc (MRBL.CN) is 0% . This number represents the probability that MRBL.CN will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating MRBL.CN's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
MRBL.CN - Historical Solvency Measures
to of
Page of
MRBL.CN - ESG ratings
ESG ratings are directly linked to the cost of capital and MRBL.CN's ability to raise funding, both of which can significantly affect the probability of Marble Financial Inc going bankrupt.
ESG Score
0
Environment Score
0
Social Score
0
Governance Score
0
| Returns | |
| Historical Returns (5 day) | 5.26% |
| Historical Returns (MTD) | - |
| Historical Returns (YTD) | - |
| Historical Returns (13 week) | -30.77% |
| Historical Returns (26 week) | -18.18% |
| Historical Returns (52 week) | -35.71% |
| Efficiency | |
| Asset Turnover | 0.31 |
| Receiveable Turnover | 9.14 |
| Gross Margin | - |
| Operating Margin | 648.4% |
| Pretax Margin | 631.3% |
| Net Margin | 631.3% |
| Return on Asset (ROA) | -56.47 |
| Return on Equity (ROE) | -52.17 |
| Return on Investments (ROI) |
| Price Metrics | |
| Market Cap (M) | 12 |
| Enterprise Value (M) | 13.5 |
| 52 Week High | 0.05 |
| 52 Week Low | 0.05 |
| Beta | -0.37 |
| Average Volume (10 day) | 0.01 |
| Average Volume (3 month) | 0.01 |
| Price / Earnings (P/E) | - |
| Price / Sales (P/S) | 9.5 |
| Earnings | |
| EPS | -0.03 |
| Revenue CAGR (5 year) | -1.49% |
| Risk | |
| Current Ratio | 0.11 |
| Quick Ratio | 0.09 |
MRBL.CN - Peer Comparisons
| Ticker | Company Name | Beta | Probability of Bankruptcy |
| a | |||
| CORT | Corcept Therapeutics Inc | -0.01 | 2.8% |
| PAHC | Phibro Animal Health Corp | 0.96 | 8.8% |
| PCRX | Pacira Biosciences Inc | 0.95 | 32.3% |
| TARO | Taro Pharmaceutical Industries Ltd | 0.81 | 79.5% |